MedTrace Logo

APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias

NCT00170274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2025-07-03

No results posted yet for this study

Summary

The goal of APART is the assessment of the therapeutic and preventive stimulation algorithms of the Medtronic AT500 and following devices in patients with atrial tachyarrhythmias and an indication for cardiac pacing according to the German guidelines. Medication is controlled throughout the study with a beta-blocker as the only antiarrhythmic drug.

Conditions

  • Tachyarrhythmia

Interventions

DEVICE

Activation of preventive and therapeutic algorithms for treatment of AF

Algorithms in At 500 or Enrhyhtm for prevention and termination of Atrial Fibrillation

DEVICE

AF Prevention and Therapy Algorithms On

Activation of AF-prevention and termination algorithms in AT 500 or EnRhyhtm

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Uwe Wiegand, MD · Universitätsklinik Lübeck Schleswig-Holstein, Campus Lübeck

  • Christian Wolpert, MD · Universitätsklinik Mannheim

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-08-31
Primary Completion
2011-06-30
Completion
2014-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00170274 on ClinicalTrials.gov